FINNENCE ▪ THE WIRE FILE
THE WIRE · № 56082
News■ Unclear/unknown
New study reveals major impact of climate change on skin health worldwide
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-09-29 22:01 UTC
LAST UPDATE2026-09-29 22:01 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Climate-linked skin disease burden could raise dermatology demand and healthcare costs over time.
Long-run health demand signal, slow-moving
CATALYST TO WATCH
Further epidemiological data releases
MAIN RISK
Diffuse impact, no clear beneficiary
FULL DISPATCH
More than 40% of countries worldwide have reported climate-related changes in the prevalence and/or severity of skin disease, with lower-income countries disproportionately affected, according to a major international study spanning 136 countries. VIENNA, Sept. 30, 2026 /PRNewswire/ --...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Essentia Health and HealthPartners CEOs discuss merger between companies2026-09-29 22:13 UTC
Essentia Health and HealthPartners CEOs discuss merger between companies2026-09-29 22:13 UTC
→CORRELATIONshares Healthcare
Wake County leaders tout growth, defend WakeMed-Atrium merger2026-09-29 22:18 UTC
Wake County leaders tout growth, defend WakeMed-Atrium merger2026-09-29 22:18 UTC
→CORRELATIONshares Healthcare
MN Attorney General promises public meetings on hospital merger and explains process2026-09-29 21:24 UTC
MN Attorney General promises public meetings on hospital merger and explains process2026-09-29 21:24 UTC
→CORRELATIONshares Healthcare
Minnesota Nurses Association raising 'serious concerns' over Essentia merger with HealthPartners2026-09-29 22:12 UTC
Minnesota Nurses Association raising 'serious concerns' over Essentia merger with HealthPartners2026-09-29 22:12 UTC
→CORRELATIONshares Healthcare
Vanda Pharmaceuticals Announces Positive Phase III Results for HETLIOZ®(tasimelteon) in Delayed Sleep-Wake Phase Disorder2026-09-29 22:45 UTC
Vanda Pharmaceuticals Announces Positive Phase III Results for HETLIOZ®(tasimelteon) in Delayed Sleep-Wake Phase Disorder2026-09-29 22:45 UTC
←CORRELATIONshares Healthcare
HealthPartners and Essentia to merge, creating one of Minnesota’s largest health systems2026-09-29 14:52 UTC
HealthPartners and Essentia to merge, creating one of Minnesota’s largest health systems2026-09-29 14:52 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.